WitrynaThe Trial Summary (TS) domain is a trial-level dataset that allows for the submission of a high-level view of a study in a structured format. Each record contains the value of a parameter or characteristic of the trial. It is used to record basic information about the study such as trial phase, protocol title, and trial objectives. WitrynaIn IMPROVE-IT, the addition to statin therapy of a nonstatin agent, ezetimibe, which reduces the absorption of cholesterol from the gastrointestinal tract, lowered LDL cholesterol by approximately...

InMoment uses ChatGPT tech to improve customer experience

Witryna20 wrz 2005 · Brief Summary: This is a randomized, active-control, double-blind study of subjects with stabilized high-risk acute coronary syndrome (ACS). The primary … Witryna3 lut 2024 · Lay Summary Non-Hispanic Black Americans experience the highest, and most rapidly increasing, rates of obesity and diseases attributed at least in part to poor diet quality. In contrast to restrictive diets, which can be ineffective and often harmful, there is a well-established connection between home cooking and lower body mass … old time trucks.org

IMProved Reduction of Outcomes: Vytorin Efficacy International Trial ...

Witryna17 lis 2014 · A. Adding ezetimibe, a non-statin agent, to statin therapy reduces cardiovascular events in high-risk patients with acute coronary syndrome (ACS), according to results of the IMPROVE-IT Trial presented Nov. 17 at AHA 2014. The study was led by Christopher P. Cannon, MD, FACC, professor of medicine at Harvard … Witryna12 lut 2024 · The IMPROVE-IT trial evaluated the effect of ezetimibe in combination with simvastatin, as compared to simvastatin alone, in stable patients with recent history of an acute coronary syndrome (ACS) with LDL cholesterol … Witryna21 lis 2024 · IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients … is a cock a chicken or rooster